Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays

Lateral flow immunoassays (LFIA) for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are used for population surveillance and potentially individual risk assessment. The performance of the SureScreen Diagnostics LFIA targeting the spike protein was evaluated in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mafi, Sarah, Rogez, Sylvie, Darreye, Jérôme, Alain, Sophie, Hantz, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829606/
https://www.ncbi.nlm.nih.gov/pubmed/36716586
http://dx.doi.org/10.1016/j.diagmicrobio.2023.115900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829606/
https://www.ncbi.nlm.nih.gov/pubmed/36716586
http://dx.doi.org/10.1016/j.diagmicrobio.2023.115900

Ejemplares similares